13709-52-9[F][Hf]([F])([F])[F]QHEDSQMUHIMDOL-UHFFFAOYSA-J13709-52-9Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
This chemical does not meet GHS hazard criteria for 2.2% (1 of 45) of reports.
Danger
H315 (88.9%): Causes skin irritation [Warning Skin corrosion/irritation]
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P354+P338, P316, P317, P319, P321, P332+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 45 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Biological Exposure Indices (BEI) [ACGIH] - Fluorides in urine = 2 mg/L prior to shift or 3 mg/L at end of shift; (Repeated measurements recommended.)
1.0 [mg/m3], inhalable fraction, as F[German Research Foundation (DFG)]
UsesHafnium(IV) fluoride is used as Vacuum deposition.
PreparationHafnium tetrafluoride may be prepared by passing anhydrous hydrogen fluoride over hafnium tetrachloride at 300°C: HfCl4 + 4HF HfF4 + HCl Another method of preparation involves thermal decomposition of ammonium fluorohafnate, (NH4)2 HfF6 [16925-24-9] in the absence of air: (NH4)2 HfF6 HfF4 + 2NH3 + 2HF Also, HfF4 can be prepared by treating metallic hafnium with 40% aqueous HF. The monohydrate formed may be heated at 350°C for several days under a flow of fluorine and nitrogen to yield anhydrous HfF4. Hf + 4HF (aq) → HfF4•H2O + 2H2
No reaction records under the current filter.
Loading…